about
From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countriesFeature engineering and a proposed decision-support system for systematic reviewers of medical evidence.The role of health technology assessment bodies in shaping drug development.Comparative effectiveness research designs: an analysis of terms and coverage in Medical Subject Headings (MeSH) and EmtreeMethods of international health technology assessment agencies for economic evaluations--a comparative analysisFrom efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmakingPharmacoepidemiology in Japan: medical databases and research achievements.UNDERSTANDING VARIATIONS IN RELATIVE EFFECTIVENESS: A HEALTH PRODUCTION APPROACHImproving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program.Management of Medical Technology under the New Medical Policy Background in ChinaA systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs.Maximizing the clinical utility of comparative effectiveness research.The cost-effectiveness of identifying and treating malnutrition in hospitals: a systematic review.Why STAN might not be dead.SCIENTIFIC AND SOCIAL VALUE JUDGMENTS FOR ORPHAN DRUGS IN HEALTH TECHNOLOGY ASSESSMENT.Precise definitions of some terminology for longitudinal clinical trials: subjects, patient populations, analysis sets, intention to treat, and related terms.Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.Comparative effectiveness research: nursing science and health care delivery.Use of relative effectiveness information in reimbursement and pricing decisions in Europe.What does it mean to be pragmatic? Pragmatic methods, measures, and models to facilitate research translation.Link between process and appraisal in coverage decisions: an analysis with structural equation modeling.Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug responseInterpretation and Impact of Real-World Clinical Data for the Practicing ClinicianIncorporating local information and prior expert knowledge to evidence-informed mental health system research
P2860
Q30665610-DB2F3755-6592-44AA-A08E-1F6A7C2AF639Q31148971-D32195E7-EE25-44FC-B96C-ED863AFCE0EFQ34524056-4428CD7F-297B-4CAC-AE45-8AC13F4068AEQ34706606-1AF961D5-5FA6-40D4-8E5B-521621533BC5Q35002534-FB44EC74-CAF6-4CAA-96C8-18E6BB35D4C1Q36390478-1B1743B3-F9BF-426F-9C87-C699599B858EQ36508734-CFF242CE-62E3-4834-8BB2-3EF3080C05CAQ36778700-943262CD-A55D-42BA-BCDE-E2E4AF661F19Q36928792-634DBBFC-60D8-47AD-973C-F07905F2AFC9Q37447514-9A79D206-C6D2-4469-A618-C0039377FDB2Q37610459-244D60F0-25F1-438C-A6EC-B793CC777907Q37801836-C1153532-AB0D-4680-8C91-083C914314D9Q38390754-4AA2B842-D0A9-4ACE-A2DD-A4E489FEE3E9Q38800000-A316CEAD-3119-44E6-B7C8-D6113064CE1AQ38821595-D3706B62-05A4-474D-8FE1-176C05AF7F5AQ39398920-7F15F8B8-53AA-458E-BA1A-3471295CAEBBQ41402538-A51ACAEE-EFC9-4EBD-93B4-0B509892C38CQ44634877-390A3B82-584E-4F9F-AC3C-31FDE5A812ECQ45108754-1FF42CB6-CD07-4CD7-BEC1-54FD015EE2E4Q45402244-8155B458-7DBA-45B0-B986-77AF51A5902BQ51200231-4B643A3D-088C-4ABC-A2AB-B3D9A9807F66Q55031510-1AC267FE-93A3-43ED-B047-2EF32C7ADE3FQ56828560-8253380E-D7AA-450E-AE93-A208E6D6A212Q57789414-D19D5019-A757-4B54-A01B-FEB0CF2810A3Q58231107-15555A3C-8BB9-4BAE-BBB1-2FAFBBE03E85
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
EBM, HTA, and CER: clearing the confusion
@ast
EBM, HTA, and CER: clearing the confusion
@en
EBM, HTA, and CER: clearing the confusion
@nl
type
label
EBM, HTA, and CER: clearing the confusion
@ast
EBM, HTA, and CER: clearing the confusion
@en
EBM, HTA, and CER: clearing the confusion
@nl
prefLabel
EBM, HTA, and CER: clearing the confusion
@ast
EBM, HTA, and CER: clearing the confusion
@en
EBM, HTA, and CER: clearing the confusion
@nl
P2093
P2860
P1433
P1476
EBM, HTA, and CER: clearing the confusion
@en
P2093
Bengt Jönsson
Bryan R Luce
J Sanford Schwartz
Michael Drummond
Peter J Neumann
Sean D Sullivan
P2860
P304
P356
10.1111/J.1468-0009.2010.00598.X
P407
P50
P577
2010-06-01T00:00:00Z